TY  - JOUR
AU  - Angelis, A
AU  - Linch, M
AU  - Montibeller, G
AU  - Molina-Lopez, T
AU  - Zawada, A
AU  - Orzel, K
AU  - Arickx, F
AU  - Espin, J
AU  - Kanavos, P
PY  - 2019
DO  - 10.1016/j.socscimed.2019.112595
UR  - http://hdl.handle.net/10668/14876
T2  - Social science & medicine (1982)
AB  - Multiple Criteria Decision Analysis (MCDA) has emerged as a methodology for Health Technology Assessment (HTA). However, limited empirical evidence is available on its use by decision-makers; where available, it only comes from single-setting...
LA  - en
PB  - BioMed Central Ltd.
KW  - Advance Value Framework (AVF)
KW  - Decision conference
KW  - Decision making
KW  - Health Technology Assessment (HTA)
KW  - Multiple Criteria Decision Analysis (MCDA)
KW  - Oncology
KW  - Pharmaceuticals
KW  - Value assessment
KW  - Belgium
KW  - Decision Making
KW  - Decision Support Techniques
KW  - Europe
KW  - Humans
KW  - Poland
KW  - Spain
KW  - Sweden
KW  - Technology Assessment, Biomedical
TI  - Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework.
TY  - research article
VL  - 246
ER  -